Vulnerability in Supremainc Biostar 2

CVE-2023-31923

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.009 (58.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 58th percentile — 58.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2023-31923: held from 0.009 to 0.009.

EPSS over last 30 days · oldest: 0.009 · newest: 0.009 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2023-31923?
CVE-2023-31923 is a high-severity vulnerability in Supremainc Biostar 2, classified under Improper Preservation of Permissions. CVSS score: 8.8/10. Published 2023-05-22.
How severe is CVE-2023-31923?
High severity. CVSS v3 base score is 8.8 out of 10.